Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Shilpa Medicare Ltd. is a biopharmaceutical company engaged in the manufacturing and commercialization of active pharmaceutical ingredients (APIs) and finished dosage forms. Established to cater to the fast-growing global healthcare sector, Shilpa Medicare plays a vital role in providing essential pharmaceuticals across various therapeutic areas, including oncology, anti-infectives, and cardiovascular drugs. As a key player in the pharmaceutical industry, the company focuses on innovation and quality, underlining its commitment to sustainable healthcare solutions. Shilpa Medicare Ltd. extends its capabilities to the development of novel drug delivery systems and biosimilars, reinforcing its position in the competitive biopharmaceutical landscape. By adhering to stringent global regulatory standards, the company ensures the efficacy and safety of its products. Shilpa Medicare's operations significantly impact sectors like hospitals, clinics, and retail pharmacies, bolstering its reputation in both domestic and international markets. Through strategic partnerships and a robust R&D infrastructure, Shilpa Medicare Ltd. remains a pivotal entity in the ongoing advancement of healthcare accessibility and excellence.